Jerome Jabbour
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $598,000 | $598,000 |
| 2023 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $598,000 | $1,599,551 |
| 2022 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $575,000 | $1,674,207 |
| 2021 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $545,000 | $3,693,314 |
| 2020 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $500,000 | $2,930,085 |
| 2019 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $444,792 | $1,325,176 |
| 2018 | Matinas BioPharma Holdings, Inc. (MTNB) | CEO | $366,458 | $1,254,727 |
Earnings-call appearances
-
Matinas BioPharma Holdings, Inc. Q4 FY2023 Earnings Call2024-03-27
Matinas BioPharma Holdings, Inc. (MTNB)
-
Matinas BioPharma Holdings, Inc. Q1 FY2022 Earnings Call2022-05-12
Matinas BioPharma Holdings, Inc. (MTNB)
-
Matinas BioPharma Holdings, Inc. Q4 FY2021 Earnings Call2022-03-08
Matinas BioPharma Holdings, Inc. (MTNB)
-
Matinas BioPharma Holdings, Inc. Q3 FY2021 Earnings Call2021-11-08
Matinas BioPharma Holdings, Inc. (MTNB)
-
Matinas BioPharma Holdings, Inc. Q2 FY2021 Earnings Call2021-08-10
Matinas BioPharma Holdings, Inc. (MTNB)
-
Matinas BioPharma Holdings, Inc. Q1 FY2021 Earnings Call2021-05-10
Matinas BioPharma Holdings, Inc. (MTNB)
-
Matinas BioPharma Holdings, Inc. Q4 FY2020 Earnings Call2021-03-29
Matinas BioPharma Holdings, Inc. (MTNB)
-
Matinas BioPharma Holdings, Inc. Q3 FY2020 Earnings Call2020-11-06
Matinas BioPharma Holdings, Inc. (MTNB)